Insight

Elvina Almuradova: Our New Paper on RAS Mutations in mCRC is Just Out in Medicina

Elvina Almuradova/LinkedIn

Jul 2, 2025, 09:34

Elvina Almuradova: Our New Paper on RAS Mutations in mCRC is Just Out in Medicina

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on X about a paper she co-authored with colleagues published in Medicina:

“Our New paper on RAS mutations in mCRC is just out in Medicina! KRAS/NRAS, resistance, new G12C inhibitors and more.”

Title: RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches

Authors: Osman Sütcüoğlu, Hasan Çağrı Yıldırım, Elvina Almuradova, Damla Günenç, Şuayib Yalçın.

You can read the Full Article in Medicina.

Elvina Almuradova: Our New Paper on RAS Mutations in mCRC is Just Out in Medicina

More posts featuring Elvina Almuradova.

cancer colorectal cancer Damla Günenç Elvina Almuradova Hasan Cagri Yildirim mCRC Medicina OncoDaily Oncology Osman Sütcüoğlu RAS mutations Suayib Yalcin

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders